Challenges for licensure of new diphtheria, tetanus toxoid, acellular pertussis (DTaP) combination vaccines: Counterpoint

被引:7
作者
Edwards, KM [1 ]
Decker, MD [1 ]
机构
[1] VANDERBILT UNIV,COLL MED,DEPT PREVENT MED & MED,DIV INFECT DIS,NASHVILLE,TN 37240
关键词
combination vaccines; pertussis antigen;
D O I
10.1097/00006454-199612000-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1070 / 1073
页数:4
相关论文
共 13 条
[1]  
[Anonymous], 1988, LANCET, Vi, P955
[2]   ISSUES IN DESIGN OF CLINICAL-TRIALS OF COMBINATION VACCINES [J].
DECKER, MD ;
EDWARDS, KM .
COMBINED VACCINES AND SIMULTANEOUS ADMINISTRATION: CURRENT ISSUES AND PERSPECTIVES, 1995, 754 :234-240
[3]  
EDWARDS EM, 1996, NAT I HLTH C AC PERT
[4]   COMBINATION VACCINES - HOPES AND CHALLENGES [J].
EDWARDS, KM ;
DECKER, MD .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (05) :345-347
[5]  
EDWARDS KM, 1995, PEDIATRICS, V96, P548
[6]  
EDWARDS KM, 1991, PEDIATRICS, V88, P1019
[7]  
ESKOLA J, 1995, 35 INT C ANT AG CHEM, P160
[8]  
GRANOFF DM, 1996, PEDIAT INFECT DIS, V15
[9]   A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine [J].
Gustafsson, L ;
Hallander, HO ;
Olin, P ;
Reizenstein, E ;
Storsaeter, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :349-355
[10]  
HEININGER U, 1996, NAT I HLTH C AC PERT